CD40 LIGAND IS A T-CELL GROWTH-FACTOR

被引:116
作者
ARMITAGE, RJ [1 ]
TOUGH, TW [1 ]
MACDUFF, BM [1 ]
FANSLOW, WC [1 ]
SPRIGGS, MK [1 ]
RAMSDELL, F [1 ]
ALDERSON, MR [1 ]
机构
[1] IMMUNEX RES & DEV CORP, DEPT IMMUNOBIOL & MOLEC BIOL, SEATTLE, WA USA
关键词
CD40; LIGAND; T-CELLS;
D O I
10.1002/eji.1830230941
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD40 ligand (CD40L) is a 33-kDa type II membrane glycoprotein induced on T cells upon activation. CD40L has previously been shown to induce proliferation of resting B cells, immunoglobulin (Ig) secretion from B cells cultured with cytokines and cytokine secretion and tumoricidal activity from monocytes. In this report CD40L is shown to be stimulatory for human T cells, inducing CD25 (p55 IL-2R) and CD40L expression on resting peripheral blood T cells, enhanced expression of these molecules and CD69 on CD3-activated cells and secretion of interferon-gamma, tumor necrosis factor-alpha and interleukin (IL)-2 from T cells cultured in the presence of a sub-mitogenic concentration of phytohemagglutinin A (PHA). Furthermore, stimulation with CD40L induces proliferation of CD3- or PHA-activated T cells of blood, tonsillar or thymic origin. A similar proliferative response is observed with CD4+ and CD8+ T cells and this effect is largely IL-2 independent. A soluble construct of the extracellular domain of the CD40L has similar activity to that of membrane-expressed ligand in the induction of T cell surface antigens and proliferation. The results presented here taken together with the various activities ascribed for CD40L on B cells and monocytes demonstrate that CD40L has pleiotropic biological activity for cells of the hemopoietic lineage.
引用
收藏
页码:2326 / 2331
页数:6
相关论文
共 68 条
  • [1] INTERLEUKIN-7 INDUCES CYTOKINE SECRETION AND TUMORICIDAL ACTIVITY BY HUMAN PERIPHERAL-BLOOD MONOCYTES
    ALDERSON, MR
    TOUGH, TW
    ZIEGLER, SF
    GRABSTEIN, KH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 923 - 930
  • [2] ALDERSON MR, 1993, IN PRESS J EXP MED
  • [3] ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671
  • [4] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [5] ARMITAGE RJ, 1990, J IMMUNOL, V144, P938
  • [6] FUNCTIONAL EXPRESSION OF B7/BB1 ON ACTIVATED LYMPHOCYTES-T
    AZUMA, M
    YSSEL, H
    PHILLIPS, JH
    SPITS, H
    LANIER, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) : 845 - 850
  • [7] LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40
    BANCHEREAU, J
    DEPAOLI, P
    VALLE, A
    GARCIA, E
    ROUSSET, F
    [J]. SCIENCE, 1991, 251 (4989) : 70 - 72
  • [8] BARRETT TB, 1991, J IMMUNOL, V146, P1722
  • [9] SYNERGISTIC T-CELL ACTIVATION VIA THE PHYSIOLOGICAL LIGANDS FOR CD2 AND THE T-CELL RECEPTOR
    BIERER, BE
    PETERSON, A
    GORGA, JC
    HERRMANN, SH
    BURAKOFF, SJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) : 1145 - 1156
  • [10] CALLARD RE, 1990, CYTOKINES B LYMPHOCY, P65